|
|
 |
| |
|
Home > Drug Companies > Medicis, Th eDermatology Company
Medicis, Th eDermatology Company
Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and podiatric conditions and aesthetics medicine. The Company is dedicated to helping patients attain a healthy and youthful appearance and self image. The firm has leading branded prescription products in a number of therapeutic categories, including acne, eczema, fungal infections, psoriasis, rosacea, seborrheic dermatitis and skin and skin structure infections. Additionally, the company markets the leading dermal filler in the U.S., Restylane.
With a keen eye for new opportunities, combined with its strong financial condition, they seek to expand its already successful business into new markets. The firm has completed several company, product and technology acquisitions, and expects to continue its vigorous business development program as an important element of its four part growth strategy.
They are committed to continued growth and are interested in learning about prospective opportunities in the specialty pharmaceutical market. They are actively expanding its portfolio of products through new product development, acquisitions, licensing agreements and promotions of late stage or previously approved products. Additionally, they seek to acquire companies with products or services in the specialty pharmaceutical niche.
The Audit Committee of the Board of Directors of Medicis Pharmaceutical Corporation was established by the action of the Board as permitted by the Bylaws of the Company. This Charter is intended to supplement the Bylaw provisions and to specify in more detail the membership and responsibilities of the Audit Committee.
Their mission is simple, they are dedicated to helping patients attain a healthy and youthful appearance and self image. Medicis develops and markets prescription products for the dermatology and podiatry specialties in the U.S. and Canada. The aesthetics subsidiary of their business markets Restylane for long lasting treatment of facial wrinkles and folds.
Back to Drug Companies
|
|
|
|
|
|
|
|